April 13 (Reuters) - Cybin Inc CYBN.NLB :* CYBIN ADVANCES IND-ENABLING STUDIES OF TWO PSYCHEDELIC MOLECULES, CYB003 AND CYB004 FOR INVESTIGATIONAL NEW DRUG APPLICATIONS
March 3 (Reuters) - Cybin Inc CYBN.NLB :* CYBIN INC. ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET
Jan 18 (Reuters) - Cybin Inc CYBN.NLB :* CYBIN ANNOUNCES CDN$20 MILLION BOUGHT DEAL OFFERING* CYBIN-ENTERED INTO AGREEMENT WITH CANACCORD GENUITY ON BEHALF OF A SYNDICATE OF...
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company’s development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a discovery-phase phenethylamine derivative to treat neuroinflammation and psychiatric conditions. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Neutral | Buy | Neutral | Sell |
| Technical Indicators | Buy | Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Buy | Neutral | Strong Buy | Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2.12 | 2.93 | 2.07 | -1.350 | -38.90% | 7.41M | Toronto | |||
| 0.12 | 0.13 | 0.11 | 0.0000 | 0.00% | 50.50K | CSE | |||
| 0.10 | 0.11 | 0.095 | -0.010 | -9.09% | 2.03M | CSE | |||
| 0.3075 | 0.325 | 0.30 | -0.0175 | -5.38% | 1.17M | Toronto | |||
| 9.66 | 9.77 | 9.63 | 0.00 | 0.00% | 77.36K | Toronto | |||
| 95.44 | 95.84 | 95.10 | +0.21 | +0.22% | 682.62K | Toronto | |||
| 3.80 | 3.84 | 3.68 | +0.050 | +1.33% | 374.31K | Toronto | |||
| 0.95 | 0.99 | 0.94 | -0.020 | -2.06% | 225.67K | Toronto | |||
| 0.53 | 0.54 | 0.51 | -0.0100 | -1.85% | 144.17K | TSXV | |||
| 0.42 | 0.425 | 0.405 | +0.0200 | +5.00% | 65.56K | TSXV | |||
| 5.73 | 5.74 | 5.59 | +0.1200 | +2.14% | 160.62K | Toronto | |||
| 148.46 | 150.54 | 144.25 | -2.15 | -1.43% | 51.38K | Toronto | |||
| 69.30 | 69.74 | 68.70 | +0.63 | +0.92% | 730.19K | Toronto | |||
| 10.32 | 10.48 | 10.22 | -0.190 | -1.81% | 107.31K | Toronto | |||
| 0.04 | 0.04 | 0.035 | 0.000 | 0.00% | 7.19M | Toronto |